Results 71 to 80 of about 2,054,122 (239)

Prognostic role of TAPSE to PASP ratio in outpatients with left ventricular systolic dysfunction

ESC Heart Failure, Volume 12, Issue 2, Page 912-922, April 2025.
Abstract Aims Few data are available regarding the role of tricuspid annulus plane systolic excursion to pulmonary artery systolic pressure (TAPSE/PASP), a measurement of right ventricular to pulmonary artery coupling, in patients with chronic heart failure and left ventricular systolic dysfunction.
Mauro Riccardi, Matteo Pagnesi, Rossana Corso, Antonio M. Sammartino, Daniela Tomasoni, Riccardo M. Inciardi, Carlo M. Lombardi, Marianna Adamo, Savina Nodari, Marco Metra   +9 more
wiley   +1 more source

Transcatheter therapies for tricuspid valve regurgitation

, 2020
: Tricuspid regurgitation, either isolated or associated with left-valve disease, has a strong impact on outcome. Surgical treatment of tricuspid regurgitation has increased in recent years, but in-hospital mortality remains high probably due to the risk
Fiorina C., Metra M., Adamo M., Zaccone G., Di Pasquale M., Curello S.   +5 more
core   +1 more source

Choosing Between Tricuspid Repair or Replacement: Decision Algorithms

Structural Heart
Transcatheter tricuspid valve (TV) interventions have transformed the treatment of TV disease. Among available therapies, transcatheter tricuspid edge-to-edge repair has shown favorable safety, symptom relief, quality-of-life improvement, and reduction ...
Hannah Kempton, MD, Lukas Stolz, MD, Ludwug Weckbach, MD, Thomas Stocker, MD, Philipp Doldi, MD, Michael Näbauer, MD, Steffen Massberg, MD, Fabien Praz, MD, Jörg Hausleiter, MD   +8 more
doaj   +1 more source

Sleep‐disordered breathing in valvular heart disease: A Modifiable comorbidity

Sleep Research, EarlyView.
Abstract Sleep‐disordered breathing (SDB) is highly prevalent among patients with valvular heart disease (VHD) and is independently associated with adverse clinical outcomes. The two major phenotypes—obstructive sleep apnea (OSA) and central sleep apnea (CSA)—exhibit distinct distributions across VHD subtypes. CSA predominates in severe aortic stenosis,
Wu Juan, Chen Ze, Zhang Qun, Chen Qiuyuan, Su Mei, Zhang Xilong, Ding Ning   +6 more
wiley   +1 more source

Risk factor analysis of arrhythmia, aortic, and tricuspid regurgitation in children with ventricular septal defect following transcatheter closure

Zdorovʹe Rebenka
Background. Ventricular septal defect (VSD) is a prevalent congenital heart disease in children, occurring at a rate of 5.27 per 1000 live births. Transcatheter VSD closure is a potentially effective alternative to surgery, considering its less invasive ...
Alif Mutahhar, Mahrus A. Rahman
doaj   +1 more source

Transcatheter versus surgical closure of ventricular septal defect: a comparative study

The Cardiothoracic Surgeon, 2023
Background In many countries, surgical closure of ventricular septal defects remains the recommended approach of ventricular septal defect closure.
Hamdy Singab, Mohamed Khairat Elshahat, Ahmed Samy Taha, Yasmin Abdelrazek Ali, Ahmed Meawad El-Emam, Mohamed Ahmed Gamal   +5 more
doaj   +1 more source

Leadless Pacemaker Implantation in High‐Risk Patients: Real‐World Outcomes From a Multicenter Israeli Registry

Pacing and Clinical Electrophysiology, EarlyView.
ABSTRACT Introduction Transvenous pacemakers are effective but carry significant short‐ and long‐term complications. Leadless pacemakers were developed to overcome these limitations, however, data in high‐risk patients ineligible for transvenous systems remain limited.
Moshe Katz, Marianna Vander, David Luria, Moshe Rav Acha, Yoav Michowitz, Alon Barsheshet, Gregory Golovchiner, Roy Beinart   +7 more
wiley   +1 more source

Outcomes After Current Transcatheter Tricuspid Valve Intervention: Mid-Term Results From the International TriValve Registry. [PDF]

, 2019
OBJECTIVES A large, prospective international registry was developed to evaluate the initial clinical applications of transcatheter tricuspid valve intervention (TTVI) with different devices.
Nazif, Tamin, Rodés-Cabau, Josep, Maisano, Francesco, Sievert, Horst, Attinger-Toller, Adrian, Mehr, Michael, Nickening, Georg, Zuber, Michel, Hahn, Rebecca T, Ho, Edwin, Alessandrini, Hannes, Webb, John G, Yzeiray, Ermela, Brochet, Eric, Frerker, Christian, Asami, Masahiko, Puri, Rishi, Lauten, Alexander, Hausleiter, Jörg, Vahanian, Alec, Himbert, Dominique, Biasco, Luigi, Schofer, Joachim, Windecker, Stephan, Latib, Azeem, Juliard, Jean-Michel, Kaple, Ryan, Tanner, Felix C, Pozzoli, Alberto, Praz, Fabien, Connelly, Kim A, Tang, Gilbert H L, Englmeier, Andrea, Deuschl, Florian, Fam, Neil, Braun, Daniel, Sievert, Kolja, Pedrazzini, Giovanni, Denti, Paolo, Lurz, Philipp, Kreidel, Felix, Schäfer, Ulrich, Kuck, Karl-Heinz, Leon, Martin B, Ancona, Marco, Taramasso, Maurizio   +45 more
core   +1 more source

Transcatheter repair of a quadricuspid tricuspid valve with severe regurgitation: a case report

Journal of Cardiothoracic Surgery
Background Moderate-to-severe tricuspid regurgitation (TR) represents the most prevalent right heart disorder. If left untreated, it may progress to heart failure and elevate mortality risk.
Jingyuan Huo, Qiyao Yu, Kaishuai Wu, Chen Wang, Haoyang Li, Zhen Wang, Weidong Li, Hongfei Xu   +7 more
doaj   +1 more source

Transcatheter Tricuspid Valve Clinical Trials: Incomplete Data and FDA-Approved Devices

Structural Heart
Each reviewed trial of transcatheter tricuspid valve intervention demonstrated clinically meaningful improvement in Kansas City Cardiomyopathy Questionnaire (KCCQ)-defined quality of life and favorable right ventricular remodeling.
Deborah Furman, MD, Brian Whisenant, MD
doaj   +1 more source